Skip to content

A study of the efficacy of the addition of a ropivacaine infusion to the analgesia provided by pre-emptive ropivacaine and intra-operative parecoxib for peri-operative pain management in adults undergoing elective arthroscopic rotator cuff surgery: a randomised double blind placebo controlled trial.

A study of the efficacy of the addition of a ropivacaine infusion to the analgesia provided by pre-emptive ropivacaine and intra-operative parecoxib for reduction of peri-operative pain in adults undergoing elective arthroscopic rotator cuff surgery: a randomised double blind placebo controlled trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000195550
Acronym
Pain-Buster' trial
Enrollment
158
Registered
2006-05-24
Start date
2004-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study was to assess the efficacy in reducing pain of the addition of a slow soaker infusion of Ropivacaine (a local anaesthetic) compared with a placebo of normal saline via fine catheter placed inside the sholder joint at the end of the operation. The amount of additional narcotic agents and oral analgesics required by the patients was measured between the active and placebo groups. The hypothesis was that the local analgesic did not give better pain relief or reduce the amount of extra analgesics required. In this randomised placebo controlled trial the surgeon, the patient, the ward nurses , physiotherapists and outcome assessor were all blinded to the treatment allocation.

Interventions

In patients undergoing rotator cuff surgery, either subacromial decompression or rotator cuff surgery post operative pain in the first 24 hours was treated with a slow drip continuous infusion of either Ropivacaine 0.75%. All patients had access to intra venous m

In patients undergoing rotator cuff surgery, either subacromial decompression or rotator cuff surgery post operative pain in the first 24 hours was treated with a slow drip continuous infusion of either Ropivacaine 0.75%. All patients had access to intra venous morphine or pethidine via patient controlled analgesia (PCA), and oral analgesics for breakthrough pain. The maximum and average pain for the first 12 hours and second 12 hours were analysed

Sponsors

Monash University, Jennifer Coghlan PhD Scholar, Supervisors, A/Prof. Rachelle Buchbinder and A/Prof. Andrew Forbes.
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Requiring rotator cuff surgery either subacromial decompression or tendon repair.

Exclusion criteria

Previous surgery to that shoulderFractures or tumoursIrreparable tendon tears.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026